• Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
    • Contact Us
      • About
      • Privacy Policy

Browse Tag

Trastuzumab

Biosimilars: The Center of Attraction of Pharma Industry
September 1, 2018
Pharmaceutical Articles

Editorial: Biosimilars – The Center of Attraction of Pharma Industry

Biosimilars, also known as follow-on-biologics are “duplicate” and licensed versions of the biologics that have lost their patent and are produced by some other company. Biosimilars have no clinically meaningful differences from the original or reference product. Moreover, regulations for biosimilar play an important

More
Biosimilars: The Center of Attraction of Pharma Industry
Pharmaceutical Articles

Editorial: Biosimilars – The Center of Attraction of Pharma Industry

September 1, 2018

Biosimilars, also known as follow-on-biologics are “duplicate” and licensed versions of the biologics that have lost their patent and are

More
  • APAC overview: trends, challenges, and possibilities for growth in the MarTech sector
  • Modernizing Therapeutic Cell Production
  • Neuraxpharm completes its presence in Benelux
  • Pharma Mirror Q&A with Jane Myles, Vice President of Clinical Trial Innovation at Curebase
  • Leg Veins: Why They Appear and How Vein Doctors Treat Them?

© 2010-2022 PharmaMirror.com - All Rights Reserved.

  • Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
  • Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
    • Contact Us
      • About
      • Privacy Policy
Go toTop